Company data
BioMarin Pharmaceutical Inc. employees and revenue per employee
BMRN · Biotechnology · $11.1B market cap
BioMarin Pharmaceutical Inc. had 3,221 employees at the end of fiscal Dec 2025, up 6.0% from a year earlier. Revenue for the year was $3.22B, up 12.9% from a year earlier, or $1.00M per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
3,221
+6.0% YoY
Revenue
$3.22B
+12.9% YoY
Revenue / employee
$1.00M
Peer median $602K
Rank in industry
14 of 39
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 3,221 | $3.22B | $1.00M | +6.0% | +12.9% |
| Dec 2024 | 3,040 | $2.85B | $939K | -10.6% | +18.0% |
| Dec 2023 | 3,401 | $2.42B | $711K | +10.4% | +15.4% |
| Dec 2022 | 3,082 | $2.10B | $680K | +1.2% | +13.5% |
| Dec 2021 | 3,045 | $1.85B | $606K | -0.5% | -0.8% |
| Dec 2020 | 3,059 | $1.86B | $608K | +1.9% | +9.2% |
| Dec 2019 | 3,001 | $1.70B | $568K | +5.3% | +14.3% |
| Dec 2018 | 2,849 | $1.49B | $523K | +10.4% | +13.5% |
| Dec 2017 | 2,581 | $1.31B | $509K | +12.6% | +17.6% |
| Dec 2016 | 2,293 | $1.12B | $487K | — | — |
Open roles: we have not matched a verified job board for this company yet.
BioMarin Pharmaceutical Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| UTHR United Therapeutics Corporation | 1,400 | $3.18B | $2.27M | Efficient growth |
| EXEL Exelixis, Inc. | 1,077 | $2.32B | $2.15M | Leaner |
| INCY Incyte Corporation | 2,844 | $5.14B | $1.81M | Efficient growth |
| PTCT PTC Therapeutics, Inc. | 991 | $1.73B | $1.75M | Efficient growth |
| ALNY Alnylam Pharmaceuticals, Inc. | 2,500 | $3.71B | $1.49M | Efficient growth |
| NBIX Neurocrine Biosciences, Inc. | 2,000 | $2.86B | $1.43M | Efficient growth |
| BMRN BioMarin Pharmaceutical Inc. | 3,221 | $3.22B | $1.00M | Efficient growth |
| MRNA Moderna, Inc. | 4,700 | $1.94B | $414K | Contracting |
| FTRE Fortrea Holdings Inc. | 14,300 | $2.72B | $190K | Leaner |
Questions about BioMarin Pharmaceutical Inc.
- How many employees does BioMarin Pharmaceutical Inc. have?
- BioMarin Pharmaceutical Inc. reported 3,221 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 6.0% from a year earlier.
- What is BioMarin Pharmaceutical Inc.'s revenue per employee?
- BioMarin Pharmaceutical Inc. brought in $3.22B of revenue in fiscal Dec 2025, which is $1.00M per employee. That ranks 14 of 39 companies we track in Biotechnology, where the median is $602K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare BMRN with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in BioMarin Pharmaceutical Inc.'s annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell BMRN.